Replies to post #556772 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Again, it gets back to the cost benefit of waiting.

I don’t think any us want to go down in the ship with her because she’s applying bad judgement and waiting too long.

A bird in the hand is worth two in the bush.

[ilovetech]

Hankman - If BP is looking at a large price tag, let's just assume for arguments sake, it would make sense to hold on to cash until NWBO has a product ready to hit the ground running, which BP is very qualified at doing. Why sit on dead money, when you have the acquisition target covering the expenses?

ILT

[biosectinvestor]

Well, I would like to see broad interest from some BP firms. I am hoping they do have interest in deals. I’m expect they have been approached. Just makes sense.

Hopefully approached not just for GBM, but for other combinations. Some of these bigger companies should want to work with NWBO and DCVax-L, and obviously producing it for such trials is costly. The challenge is if such parties get a stake in the company and then undermine other deals with their competitors. I have seen that happen, and it’s ugly.

So it is a challenge to do this right. Both those wanting to see deals and those more hesitant have valid positions points.